Number of pages: 100 | Report Format: PDF | Published date: April 14, 2023
Historical Years – 2021 | Base Year – 2022 | Forecasted Years – 2023-2031
Report Attribute |
Details |
Market Size Value in 2022 |
US$ 3.47 billion |
Market Size Value in 2031 |
US$ 5.16 billion |
CAGR |
4.5% |
Base Year For Estimation |
2022 |
Forecast Period |
2023 to 2031 |
Historical Year |
2021 |
Segments Covered |
Product, Glass Type, and Region |
Regional Scope |
North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa |
According to the deep-dive market assessment study by Growth Plus Reports, the global pharmaceutical glass packaging market was valued at US$ 3.47 billion in 2022 and is expected to register a revenue CAGR of 4.5% to reach US$ 5.16 billion by 2031.
Pharmaceutical Glass Packaging Market Fundamentals
Pharmaceutical glass packaging uses glass as a material for containers and packaging in the pharma industry. Glass packaging is a popular choice for storing pharmaceutical glass types because it is non-reactive, impermeable, and transparent, which helps to maintain the quality and integrity of the glass type. Pharmaceutical glass packaging can take many forms, such as vials, bottles, ampoules, and syringes. Depending on the product’s specific needs, these containers can be made of various kinds of glass, such as borosilicate glass, soda-lime glass, and specialty glasses. Pharmaceutical glass packaging is designed to meet strict regulatory requirements to ensure the safety and efficacy of the glass type. These regulations include glass composition, size, shape, and labeling requirements.
[75665]
Pharmaceutical Glass Packaging Market Dynamics
The pharmaceutical industry is growing rapidly, increasing the demand for high-quality glass packaging for drugs and medicines. This is primarily due to the increasing number of chronic diseases, the aging population, and the rise in healthcare spending, all contributing to the revenue growth of the global pharmaceutical glass packaging market. For instance, according to the WHO’s factsheet of September 2022, chronic diseases kill 41 million individuals each year, which is equivalent to 74% of global deaths. Glass is an ideal material for pharmaceutical packaging as it is inert, non-reactive, and impermeable to gases and liquids, thus ensuring the safety and quality of medicines. The pharmaceutical industry is increasingly focusing on safety and quality, also driving the demand for the global pharmaceutical glass packaging market. Additionally, regulatory agencies such as the FDA and EMA require that drugs be packaged in containers that meet specific safety and quality standards. Glass packaging is considered a safe and reliable option for pharmaceutical glass types. Thus, pharmaceutical companies increasingly opt for glass packaging to comply with regulations. Moreover, glass is a 100% recyclable material, which makes it an environmentally friendly option for pharmaceutical packaging. The pharmaceutical industry is under increasing pressure to adopt sustainable practices, and glass packaging helps meet this demand.
However, glass packaging is fragile and can break easily, leading to product loss, safety concerns, and additional costs. This is particularly challenging for transportation and storage, where glass packaging must be handled carefully. While glass is ideal for pharmaceutical packaging, it faces stiff competition from other materials such as plastic, metal, and paper-based packaging. These materials are cheaper and lighter and, in some cases, can be just as effective as glass. Furthermore, glass packaging is typically more expensive than other materials, which can be a constraint for pharmaceutical companies, particularly those operating in price-sensitive markets. Glass packaging production requires raw materials such as sand, soda ash, and limestone, which are not always readily available. This can result in fluctuations in the glass packaging supply, impacting the pharmaceutical industry. Additionally, concerns over sterility, cost, and fragility are impeding the overall pharmaceutical glass packaging market revenue growth.
Pharmaceutical Glass Packaging Market Ecosystem
The global pharmaceutical glass packaging market is analyzed from three perspectives: product, glass type, and region.
Pharmaceutical Glass Packaging Market by Product
[65756]
Based on the product, the global pharmaceutical glass packaging market is segmented into bottles, vials, ampoules, cartridges and syringes, and others.
The bottles segment dominated the market with the principal revenue share in 2022, attributed to its widespread use of packaging material. Bottles are a common type of pharmaceutical glass packaging used in the pharmaceutical industry. They come in different sizes, shapes, and types of glass depending on the medication’s specific needs and the manufacturer’s requirements. Pharmaceutical bottles are typically made from either soda-lime glass or borosilicate glass, with borosilicate glass being the preferred material for its superior thermal shock resistance and chemical durability. The bottles can be clear or amber-colored, with amber-colored bottles being used for light-sensitive drugs. Pharmaceutical bottles can be used for various medications, including liquids, powders, and tablets. They are often used for medications requiring frequent or long-term dosings, such as antibiotics or blood pressure. The bottles can be equipped with various closures, including screw caps, child-resistant caps, or dropper assemblies. Glass bottles are widely used for packaging medicines and pharmaceuticals due to their durability, inertness, and impermeability to gases and liquids. These factors contribute to the revenue growth of the bottle segment.
The ampoules segment accounts for a prominent revenue share of the market. Ampoules are pharmaceutical glass packaging commonly used in the pharmaceutical industry to package injectable drugs. They are small, sealed glass containers that are designed to hold a single dose of medication. Ampoules are hermetically sealed containers, which means they are completely airtight and are intended to be opened by breaking the glass neck of the container. This ensures that the medication inside remains sterile and contamination-free until administered. The opening of the ampoule can be facilitated by using an ampoule breaker, a specialized tool designed for this purpose. Ampoules are commonly used for packaging vaccines, insulin, and other medications requiring sterile and precise dosing. They are also popular in hospitals, clinics, and healthcare settings due to their convenience and ease of use. These aspects are attributed to the revenue growth of the ampoules segment.
Pharmaceutical Glass Packaging Market by Glass Type
Based on the glass type, the global pharmaceutical glass packaging market is segmented into Type I, Type II, Type III, and Type IV glass type.
Type I glass type segment accounted for a significant share of the market. Type I glass refers to glass containers that are highly resistant to alkalis and have minimal interaction with their contents. These containers are typically made from borosilicate glass, known for its ability to withstand thermal shock and high temperatures. Type I glass is the highest quality level of pharmaceutical glass packaging and is commonly used for packaging high-value, sensitive drugs, and biologics. These types of drugs require a high level of protection against contamination, and the Type I glass containers provide an effective barrier against external factors that could affect the integrity of the contents. They are used for laboratory glass apparatus, injection water, and parenteral and non-parenteral application.
Similarly, the type II glass segment accounted for a prominent market revenue share. Type II refers to glass containers treated with a specific surface coating to increase hydrolytic resistance. These containers are commonly made from soda-lime-silica glass, which is less expensive than borosilicate glass used in Type I packaging. The Type II glass containers are designed to have improved resistance to water and alkaline solutions, making them suitable for packaging a wide range of pharmaceutical products such as oral solid dosage forms, powders, and creams. The surface coating applied to the glass container helps reduce alkali leaching from the glass, which can otherwise interact with the pharmaceutical product and lead to degradation. Alkali-sensitive items, infusion fluids, blood and plasma, and large-volume containers are all utilized in them.
Pharmaceutical Glass Packaging Market by Region
Geographically, the global pharmaceutical glass packaging market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.
North America dominated the global pharmaceutical glass packaging market with the largest revenue share in 2022, attributed to the continuous innovation in the product. Additionally, regional companies are investing in their expansion and growth, which is expected to improve the pharmaceutical glass packaging market outlook. For instance, in March 2023, Gerresheimer AG, a leading producer of healthcare and beauty solutions and drug delivery systems for pharma, biotech, and cosmetics, announced investments to rapidly expand its glass vial manufacturing, supply, and logistical expertise in the United States. The project was funded by the Biomedical Advanced Research and Development Authority (BARDA), which is part of the Office of the Assistant Secretary for Preparedness and Response (ASPR) at the Department of Health and Human Services (HHS), with contracting assistance provided by the Department of Defense (DOD). It increased Gerresheimer’s capacity by introducing new vial formation lines, which included dimensional inspection, annealing, cosmetic inspection, and packing. BARDA has agreed to pay Gerresheimer AG up to US$ 66 for this project.
Competitive Landscape of the Pharmaceutical Glass Packaging Market
The prominent players operating in the global pharmaceutical glass packaging market are:
Strategic Developments in the Pharmaceutical Glass Packaging Market
Pharmaceutical glass packaging refers to using glass for containers and packaging in the pharmaceutical industry.
North America dominated the global pharmaceutical glass packaging market with the largest revenue share in 2022.
The expected size of the global pharmaceutical glass packaging market in 2031 is US$ 5.16 billion.
The revenue CAGR of the pharmaceutical glass packaging market during the forecast period will be 4.5% from 2023 to 2031.
The concerns over sterility, cost, and fragility are factors restricting the global pharmaceutical glass packaging market revenue growth to its full potential.
*Insights on financial performance are subject to the availability of information in the public domain
Recommended Reports